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There  are  at least three  different routes  by which viruses can  spread from 
one  cell  to  another.  First, viruses  released from  infected  cells can  spread  to 
nearby or distant cells by the extracellular route  (1).  Second, viruses such  as 
herpes simplex  (HSV) I can  spread to  adjacent cells by passing through inter- 
cellular bridges  (1-3).  Third,  during  cell division viruses or  the  viral genome 
can be transmitted to progeny cells (4). The mechanism(s)  by which the host 
prevents  the  spread of extracellular virus through  neutralization by antiviral 
antibody  and  corrlplement has  been  extensively studied  (5).  Relatively little 
is known,  however,  about  how  the  immunological response  of  the  host  stops 
those viral infections which spread directly from cell to cell without ever being 
exposed to antiviral antibody. The present investigation was initiated to study 
the factors involved in preventing the spread of HSV. 
Materials  and Melhods 
Tissue Culture and Media.--Primary rabbit kidney (PRK) cells were prepared and main- 
rained as previously described  (6). Growth medium  (GM)  consisted  of Eagle's minimal es- 
sential medium  with 0.5%  lactalbumin hydrolysate, 10%  heat-inactivated calf serum,  and 
antibiotics (100 U  of penicillin/ml, 50 #g of neomycin/ml, and  100  U  of mycostatin/ml). 
Media for the infectious center assay consisted of 1% Noble agar (Difco Laboratories, Inc., 
Detroit, Mich.)  in Eagle's minimal essential  medium  containing  5%  calf serum  and  anti- 
biotics.  Dulbecco's phosphate-buffeled  saline (PBS) with Ca  ++ and Mg  ++ was used to wash 
monolayers. 
Virus.--HSV  (type 1) was prepared and assayed in PRK cells (6). Three tissue  culture 
plates were used for each virus dilution, and the average  number of plaques  per plate was 
determined. To prevent development of secondaD- plaques,  2% pooled human  serum  con- 
taining antibody to HSV was added to the growth medium  (antibody overlay medium). 
Antisera.--Antisera  against HSV were prepared by immunization  of New Zealand white 
rabbits with multiple intravenous injections of 108.0 plaque-forming  units (PFU) of partially 
purified virus (7). The 50% neutlalizatlon tlters exceeded 10,000. 
* Present address: Rocky Mountain Laboratory, Hamilton, Mont. 59840. 
1Abbreviations  used in  this paper: GM,  growth  medium;  HSV,  herpes  simplex  virus; 
MOI, multiplicity of infection;  PBS,  phosphate-buffered  saline; PFU, plaque-forming  units; 
PRK, primary labbit kidney. 
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Complement.--Pooled rabbit sera obtained flom New Zealand white rabbits served as the 
source of complement. 
Leukocytes.--Female  New Zealand white rabbits, weighing 2-3 kg, were inoculated intra- 
peritoneally with 35 ml of sterile 12.5%  sodium caseinate (Difco Laboratories). 3 days later, 
the petitoneal cavity was exposed through a mldline incision and washed with 200 ml of cold 
PBS containing 5 U of heparin/ml and antibiotics. The cells in the exudate wele centrifuged 
at 800 g for 10 man, washed twice with 20 vol of PBS, and then exposed to 15 ml of 0.2% 
NaC1 for 30 s to lyse erythrocytes. Immediately thereafter, 15 ml of 1.6%  NaC1 was added; 
the cells were centrifuged and, except where indicated, resuspended in antibody overlay me- 
dium. Approximately 75% of the cells were macrophages or monocytes, and the rest were poly- 
morphonuclear leukocytes or small lymphocytes. More than 95% of the cells were viable as 
measured by exclusion of trypan blue. The cells will be referred to hereafter as leukocytes. 
Incubation of Leukocytes with Infected Cdls.--Confluent monolayers of PRK cells in tissue 
culture trays  (Bellco  Glass,  Inc., Vineland, N. J.)  containing 24 wells  (16 mm in diameter) 
were washed once with PBS  and,  except where stated, were infected with  15-20  PFU of 
HSV suspended in 0.2 ml of GM. Mter incubation at 37°C for 2 h the inocula were aspirated; 
the monolayers were washed once and  then were incubated with either 2  ml of antibody 
overlay medium or 2 ml of antibody overlay medium containing leukocytes at a leukocyte: 
PRK cell ratio of 50:1, 25:1, or 10:1.  Except where indicated, leukocytes and medium were 
aspirated 72 h  after infection; the monolayers were washed three times with PBS and were 
examined for plaques and/or titrated for virus. All determinations were done in quadruplicate, 
and the results were expressed as the average per well. Many of the experiments were repeated 
three or more times. 
Immunofluorescence.--Anti-HSV  antibody for  direct immunofluorescence was prepared in 
rabbits by inoculation of scarified  corneal surfaces with HSV. 3 wk later,  the animals were 
bled, and the gamma globulin was conjugated with fluorescein  isothiocyanate (8). To eliminate 
nonspecific  fluorescence,  the conjugated antiserum was adsorbed  twice with  acetone-dried 
powders of rabbit liver and kidney.  Infected and uninfected PRK ceils grown on cover slips 
were fixed with acetone for 5 rain at room temperature and  then were stained at 4°C  over- 
night. Specificity  of the conjugate was  established by inhibition of staining with unlabeled 
antibody. Mter repeated washings with PBS, the cover slips were mounted in buffered glycerol 
(pH  9.0)  and  were  observed with a  Zeiss  Universal fluorescence  microscope (Carl  Zeiss, 
Inc., New York). 
Detection of  Viral  Antigens  on  the  Surface  of Infected  Cdls.--Infected  and  uninfected 
monolayers were incubated for 1 h  at 37°C  with 125I-labeled anti-HSV antibody (9).  The 
monolayers were then washed, and the amount of 1~5I that remained bound to the cells was 
determined. 
Cell Injury Measured by Rdease  of slCr.--PRK cells  were labeled with Na251CrO, and 
infected with HSV (7). At appropriate times thereafter the monolayers were incubated for 1 h 
at  37°C  with anti-HSV antibody plus  complement. Controls were incubated with normal 
rabbit serum or heat-inactivated complement. The amount of 51Cr released into the medium 
was used  to evaluate immunologically mediated cell  injury  (7).  In other experiments the 
amount of 51Cr released from labeled cells after incubation with leukocytes was used to evalu- 
ate leukocyte-mediated cell  injury. 
Infectious  Center Assay.--PRK cells grown in  60-ram  plastic Petri dishes were infected 
with HSV at a  multiplicity of infection (MOI)  of 1.0. After a 2-h incubation, the cells were 
washed twice with Eagle's minimal essential medium and overlaid with 5 ml of GM contain- 
ing 5% human serum as the source of anti-HSV antibody. At appropriate times the mono- 
layers were washed, trypsinized, and transferred to centrifuge tubes containing 7 ml  of GM 
with 5% human serum. Mter centrifugation the cells were resuspended, and the appropriate 
number of cells in a volume of 0.2 ml were plated on PRK monolayers. 1 ml of agar  overlay 
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was added. 5 days later  another 3 ml of agar overlay medium containing 0.02% neutral  red 
was added, the monolayers were examined for plaques, and the percentage of the plated cells 
that  were infected  was  calculated. 
RESULTS 
Inability of A nti-ttS V A ntibody  and Complement  to _Prevent Viral _Plaques.-- 
In  previous  experiments  we  showed  that  cells  infected  with  HSV  could  be 
destroyed  by  anti-HSV  antibody  plus  complement  (7).  This  suggested  that 
destruction  of  infected  cells  by  antiviral  antibody  plus  complement  might 
stop  the  spread  of  infection  by  preventing  the  virus  from  passing  through 
intercellular bridges to contiguous uninfected cells. To see if this were the case, 
monolayers were  infected  with  15-20 PFU  of HSV  and  then  incubated  with 
either  anti-HSV  antibody  or  anti-HSV  antibody plus  complement.  The  con- 
centrations  of  anti-HSV  antibody  and  complement  used  in  this  experiment 
were  shown  previously  to  produce  maximal  lysis  of  HSV-infected  cells  (7). 
The data in Table I  show that neither anti-HSV antibody alone nor anfi-HSV 
antibody  plus  complement  had  any  effect  on  the  number  of  plaques  that 
formed. Moreover,  the  time  of appearance  of these plaques  (data not shown) 
was the same whether or not complement was present. 
Relationship  of  Time of Appearance  of Virus-Induced  Cell Surface  Antigens, 
Immune  Lysis,  and  Transfer  of  Virus to Adjacent Cells.--The  fact  that  anti- 
viral  antibody  and  complement  can  destroy  virus-infected  cells,  but  cannot 
prevent  the  spread  of  HSV,  suggests  that  the  virus  nmst  be  transferred  to 
adjacent  cells  before  immune  lysis occurs. The next  experiment  was designed 
to study the relationship  between  the  time  of appearance  of new  antigens  on 
the surface of infected cells, the susceptibility of these cells to lysis by antiviral 
antibody  and  complement,  and  the  time  at  which virus  is  transferred  to  ad- 
jacent cells. Monolayers were infected with HSV at a MOI of 1.0 and then were 
divided  into groups to  (a)  determine  the  time of appearance  of viral  antigens 
on the surface of infected cells by the binding of 1%I-labeled anti-HSV antibody 
TABLE I 
E~ect of Anti-HSV Antibody and Complement on the Devdopment of Viral Plaques* 
Treatment  of monolayers 
Anti-HSV antibody  Complement 
No. of plaques 
1:4  None  16 
1:4  1:2  17 
1:505  None  14 
1:505  1:2  15 
* Monolayers were infected with  15-20 PFU of HSV and  then incubated  with 0.5 ml of 
the appropriate  dilutions of anti-HSV antibody and complement plus 1.5 ml of GM. Plaques 
were counted 72 h after infection; each number represents the average of four plates. 
5 Concentration  of  antibody  used in  standard  overlay  medium  to  prevent  secondary 
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(9);  (b)  evaluate  the susceptibility  of the cells  to immune  lysis by measuring 
the release  of radioactivity from ~lCr-labeled  cells  (7); and  (c)  study the time 
of  transfer  of  virus  to  adjacent  cells  by  counting  the  number  of  infectious 
centers.  The data in Fig.  1 show that small  amounts of virus-induced  antigen 
appeared  on the surface of infected cells within  7-8 h  after infection and that 
the amount of antigen  increased gradually thereafter.  Despite  the presence of 
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FIo. 1. Relationship of time of appearance of virus-lnduced ceil surface antigens, immune 
lysis, and transfer of virus to adjacent  cells• Ratio of 12~I-labeled anfi-HSV antibody (epm) 
bound  to infected cells to ]25I-labeled anti-HSV  antibody (cpm) bound to uninfected cells 
(,-m) ; ratio of 51Ct (cpm) released from infected cells by anti-HSV antibody plus complement 
to 51Cr (cpm) released from infected cells by anti-HSV antibody  plus heat-inactivated  com- 
plement  (A-'-A); ratio  of number  of infected ceils at each time interval  to number  of in- 
fected cells at 4 h  (0  Q). 
viral  antigens  on the surface of infected cells,  the cells were not susceptible  to 
immune  lysis by anti-HSV  antibody and  complement until  10-12  h  after  in- 
fection. The transfer of virus to adjacent  cells, however,  commenced at 6-7 h 
after  infection.  Thus  the  transfer  of virus  occurred  several  hours  before  im- 
mune lysis. 
Prevention of Plaque Formation by Leukocytes.--The  fact  that  the  spread  of 
virus could not be  stopped by antiviral  antibody plus  complement raised  the 
possibility that leukocytes, which often are seen at the site of herpetic lesions, 710  CELL-TO-CELL  SPREAD OF  HSV: PREVENTION BY  LEUKOCYTES 
might be needed to arrest the infection. To study the effect of leukocytes on the 
development of viral plaques, monolayers that had been infected 2  h  earlier 
were incubated with different concentrations of leukocytes. At the end of 72 h 
the  number of  plaques  was  counted.  Table  II  shows  that  leukocytes  sup- 
pressed both the development of plaques and the amount of recoverable virus. 
Moreover,  the  degree  of  suppression was  dependent on  the  concentration of 
leukocytes. 
To determine how rapidly leukocytes exerted their inhibitory effect, mono- 
layers that had been infected 2 h  earlier were incubated with leukocytes at a 
ratio  of  50:1.  At  different  times  thereafter  the  virus  titer  was  determined. 
The data in Table III show  that within 24 h  the virus titer was reduced by 
almost 99%  and  that  the  reduction in  titer persisted  throughout  the  entire 
96 h of the experiment. In other experiments (data not shown), leukocytes were 
placed on uninfected monolayers for 6,  12, or 24 h. The leukocytes then ¥ .'re 
removed, and the monolayers were infected with 15-20 PFU of HSV. Plaques 
were  counted  72  h  later.  Under  these  conditions plaques  developed  in  the 
usual way,  indicating that  the monolayers had not become refractory  to  the 
infection. 
TABLE  II 
Effect of Leukocytes  on the Development  of Viral Plaques* 
Ratio of leukocytes  to PRK cells  No. of plaques  Virus fiter 
PFU, loglo 
0  18  5.0 
10  6  3.8 
25  0  3.0 
50  0  2.8 
* Monolayers were infected with  15-20 PFU of HSV and then incubated  with different 
concentrations of leukocytes. At the end of 72 h the leukocytes were removed, the mono- 
layers were washed, and the number of plaques was determined. The monolayers then were 
removed and titrated for virus. 
TABLE  III 
Effect  of  Leukocytes  on  Virus  Titer  at  Different  Times  after  Infection* 
Hours after infection  Leukocytes  No leukocytes 
PFU, loglo 
24  1.2  3.0 
48  3.4  4.7 
72  3.4  5.3 
96  3.8  5.9 
* Monolayers that had been infected 2 h earlier with 15-20 PFU of HSV were incubated 
with leukocytes at a ratio of 50:1. At the times indicated, the leukocytes were removed and 
monolayers were washed and titrated for virus. LODlV[ELL  ET  AL.  711 
Further  evidence  that  leukocytes in  contact  with  infected  monolayers  can 
inhibit  the  development  of  viral  plaques  comes  from  fluorescent  antibody 
studies.  Monolayers were infected with HSV and at different  times  thereafter 
examined for the appearance of viral antigens. As seen in Table IV, leukocytes 
markedly inhibited both the number and the size of the fluorescent foci. How- 
ever,  in  those  cells  which  showed  fluorescence,  the  localization  (intranuclear 
and  cytoplasmic)  and  intensity  of  the  fluorescence  were  not  appreciably  af- 
fected. 
Effect of Leukocytes on  Viral Replication.--The  previous experiments showed 
that  leukocytes prevented  plaque  formation  and  reduced  the  titer  of  infec- 
tious  virus.  These  experiments,  however,  did  not  indicate  whether  this  was 
TABLE IV 
Effect of Leukocytes on Development of Viral Antigens* 
Fluorescent loci* 
Hours after infection  With leukocytes  No leukocytes 
No.  Size  No.  Size 
24  3  +  14  ++ 
48  8  ++  25  +++ 
72  7  ++  28  +++-t- 
* PRK cells on cover slips that had been infected 2 h earlier with 20-30 PFU of HSV were 
incubated  with  leukoeytes at a ratio  of 50:1.  At the times indicated,  the leukocytes were 
removed and  the  cover slips were washed and  examined by immunofluorescence for viral 
antigens. 
~: Size of fluorescent loci: +, 1-4 cells; ++,  5-20 cells; +++,  foci with holes in center; 
+ + + +, coalescence. 
due  to  the  inability  of  HSV  to  spread  from  cell  to  contiguous  cell  and/or 
inhibition of viral replication. 
To  study the  effect of leukocytes on viral  replication,  monolayers were in- 
fected with concentrations of virus sufficient to infect 100 % of the cells, thereby 
eliminating  the possibility  that  the  depression  in  titer  was due  to  the failure 
of the virus  to spread  to uninfected  cells.  Leukocytes at  a  ratio  of 50:1  then 
were added,  and at different  times  the PRK cells were examined by immuno- 
fluorescence  for  the  appearance  of  viral  antigens  and  titrated  for  infectious 
virus. In the absence of leukocytes, intranuclear  and cytoplasmic fluorescence 
were detected in  10-20 %  of the cells within  9 h  and in more than  70 %  of the 
cells  within  24 h  after  infection.  In  the presence  of leukocytes,  substantially 
fewer cells showed fluorescence, approximately  10 % fluorescing at 24 h. More- 
over,  as  seen  in  Table  V,  considerably  less  infectious  virus  was  recovered 
from  monolayers  incubated  with  high  concentrations  of  leukocytes  (50:1). 
Low  concentrations  of leukocytes  (25:1  and  10:1)  had  little  or  no  effect  on 
virus  titer,  even  though  these  same  concentrations  of  leukocytes  markedly 712  CELL-TO-CELL  SPREAD  OF  HSV:  PREVENTION  BY  LEUKOCYTES 
TABLE V 
Effect ~  Leukocyt~ on ~r~ Replicati~  in Cdlslnfect~ with a H~h MMtipllcity ~  ~rus* 
Hours after infection 
Ratio of lenkoeytes  to PRK  cells 
None  10  25  50 
-PFU, loglo 
6  1.5  1.3  1.3  1.1 
9  3.2  3.4  3.5  3.5 
12  4.4  4.6  4.6  3.8 
15  5.4  5.3  4.8  3.9 
* Monolayers were infected with HSV at a virus-to-cell ratio of 10; and 2 h later, different 
concentrations of leukocytes were added. At appropriate times thereafter  the  leukocytes 
were removed, the monolayers  were washed, and the virus titer was determined. 
suppressed the virus titer in experiments in which the cell-to-cell  spread of the 
virus was  an  important factor  (Table  II). These  observations  are  consistent 
with the hypothesis that leukocytes can inhibit both viral replication and the 
cell-to-cell  spread of the virus. 
Interaction  of  Leukocytes  with  Infected  and  Uninfected  Cells.--To  see  if 
leukocyte  viability  was  essential  in  inhibiting  viral  replication,  leukocytes 
were  heated  at  56°C  or  frozen  and  thawed  three  times.  These  treatments 
killed almost 100 % of the leukocytes as determined by trypan blue exclusion. 
The dead leukocytes then were  added  to monolayers that had been infected 
with  15-20 PFU  of HSV,  and  72  h  later  plaque  formation  and  virus  titers 
were determined. Distinct plaques formed in those monolayers that had been 
incubated  with  dead  leukocytes whereas  no plaques  were  detected  in  mono- 
layers incubated with viable leukocytes. Moreover, as seen in Table VI, dead 
leukocytes did not affect the virus titer.  Studies on the viability of the leuko- 
cytes during  the  course of a  typical experiment  revealed  that  their  viability 
decreased from 97 %  at  the beginning of the  experiment  to 56  and 34%,  re- 
spectively,  at  24  and  72  h.  Evidence  that  the  leukocytes must be  not  only 
viable but also in an "activated" state to suppress the development of plaques 
comes from experiments  in  which  leukocytes from  the  peritoneal  cavity of 
unstimulated rabbits were found to be far less effective in suppressing plaques 
than leukocytes induced by sodium caseinate. 
To  determine  whether  factors  released  from  viable  leukocytes  could pre- 
vent the development of plaques,  supernatant fluids  were harvested from un- 
infected  PRK  monolayers  that  had  been  incubated  for  different  lengths  of 
time with leukocytes at a 50:1 ratio. The supernatant fluids were reconstituted 
with an equal volume of antibody overlay medium and then added to infected 
cells. The data in Table VII show that the supernatant fluids did not prevent 
plaques.  In other experiments,  supernatant fluids  that had been concentrated 
fivefold  and  reconstituted  as  above  also  failed  to  prevent  plaques.  To  see 
whether  a  depletion  of  GM  induced by leukocytes might  be  responsible for LODMELL ET AL.  713 
TABLE  VI 
Failure of Dead Leukocytes to Suppress Virus* 
Treatment of leukocytes  Percent  viable 
Ratio of leukocytes to PRKcells 
50  25  10 
PFU, logl  o 
None  97  3.0  4.0  4.5 
Freeze-thaw~  3  5.4  5.5  5.3 
Heat~:  3  5.2  5.3  5.3 
* Monolayers that had  been infected for 2 h with 15-20 PFU of HSV were incubated 
with  different concentrations  of leukocytes. At the  end  of 72  h,  the  leukocytes were re- 
moved and the monolayers were washed and titrated for virus. In the absence of leukoeytes, 
the virus titer was 105.4 PFU per monolayer. 
2~ Leukocytes were heated at 56°C for 105 min or frozen and thawed three times. 
TABLE  VII 
Effect  of Supernatant Fluids from Leukocytes  on the Devdopment  of Viral  Plaques* 
Time at which supernatant  fluids  were harvested  No. of plaques 
h 
24  15 
48  14 
72  18 
Control~  16 
* Supernatant fluids were harvested from uninfected PRK cell monolayers that had been 
incubated for different lengths of time with leukocytes at a 50:1 ratio. The supernatant fluids 
were reconstituted with an equal volume of overlay medium and added to monolayers that 
had been infected 2 h earlier with 15-20 PFU of HSV. Plaques were counted at 72 h. 
~: Overlay medium. 
the  reduction in virus  titers,  infected monolayers that  had  been incubated 
with leukocytes at a ratio of 50:1 were refed with 1.0 ml of fresh GM at 12, 24, 
36, or 48 h  after the start of the experiment. At the end of 72 h  the leukocytes 
were  removed,  and  the  monolayers were  titrated  for  infectious virus. In all 
cases,  monolayers incubated with  leukocytes  produced  approximately  99% 
less virus than monolayers without leukocytes. 
To study in more detail the mechanism of action of leukocytes, uninfected 
monolayers were  incubated with  different  concentrations of  leukocytes  and 
examined microscopically. At high concentrations (50:1)  the leukocytes were 
clearly toxic to the cells. The toxicity was characterized by cytoplasmic granules, 
thinning of cellular cytoplasm, and spaces between adjacent cells. At lower con- 
centrations (10: 1)  the toxicity was markedly reduced. 
To evaluate more quantitatively the ability of leukocytes to  damage cells, 
monolayers that had been labeled with Na251CrO4 were incubated with leuko- 
cytes at a 50:1 ratio, and the amount of radioactivity released into the super- 
natant fluid was  determined. The data  in Table VIII show  that  leukocytes 714  CELL-TO-CELL  SPREAD  OF  HSV:  PREVENTION  BY  LEUKOCYTES 
exerted little  toxicity during the first  12 h  of incubation, but resulted in con- 
siderable release of 51Cr above controls between 12 and 24 h. 
In other studies,  the number of viable PRK cells  remaining on plates  that 
had been  incubated with  different concentrations of leukocytes for 24 h  was 
determined.  These  experiments  showed  that  leukocytes  at  a  50:1  ratio  re- 
duced the number of viable cells from 2.8  X  105 to  1.9  X  105 whereas leuko- 
cytes at a 25 : 1 ratio had little or no effect on the number of viable cells. 
Appearance  of  Viral  Plaques after Removal of Leukocytes.--To  determine  if 
leukocytes  permanently  suppressed  plaque  formation,  leukocytes  that  had 
been incubated with infected monolayers for 72 h were removed, and the mono- 
TABLE  VIII 
Toxicity of Leukocytes to PRK Call Monolayers as Measured by Release  of 51Cr* 
Treatment of monolayers  51Cr released  from monolayers at different  times after 
addition of leukocytes 
Leukocytes  Virus  6 h  12 h  24 h 
%released 
--  --  12  20  33 
--  +  13  21  34 
+  -  13  24  54 
+  +  14  23  57 
* Uninfected and infected (15-20 PFU of HSV) monolayers that had been labeled with 
Na251CrO4 were incubated with leukocytes at a 50:1 ratio, and the percentage of 5tCr re- 
leased from the cells was determined. 
layers were refed and examined at 144 h for plaques. As seen in Table IX, few 
if any plaques were present at 72 h, whereas plaques appeared after removal of 
the leukocytes. This and other experiments showed that the number of plaques 
that  ultimately  developed  was  dependent  on  the  initial  concentration  of 
leukocytes. 
Prevention of Viral Plaques after Removal of Leukocytes by A nti-HS V Antibody 
and Complement.--The fact that plaques appeared after removal of the leuko- 
cytes suggested that other factors must contribute to the cure of the infection. 
The  possibility  that  antiviral  antibody plus  complement  in  the  presence  of 
leukocytes might stop the infection was investigated. The data from a  repre- 
sentative  experiment  (Table  X)  show  that  the  development  of  plaques  was 
not  inhibited  if  infected  monolayers were  incubated  with  leukocytes  and  a 
1:16  dilution  of  anti-HSV  antibody.  However,  if  complement was  added  to 
the  reaction  mixture,  plaque  formation  was  almost  completely  suppressed. 
The  addition  of heat-inactivated  complement  did  not  suppress  the  develop- 
ment of plaques. At high concentrations of anti-HSV antibody (1:4), plaques 
were  inhibited  whether  or  not  complement  was  present.  In  the  absence  of 
leukocytes, however, neither anti-HSV antibody alone nor anti-HSV antibody LODMELL  ET  AL. 
TABLE  IX 
Appearance of Viral Plaques after Removal of Leukocytes* 
715 
Ratio of leukocytes to PRK cells 
No. of plaques 
72 h  144 h 
0  20  Confluent 
10  4  16 
25  0  12 
50  0  8 
* Monolayers were  infected with  15-20  PFU  of HSV and  then incubated with different 
concentiations of leukocytes. At the end of 72 h  the leukocytes wele removed, and the num- 
ber of plaques was determined. The monolayers then were refed, and at  144  h  the  number 
of plaques was again determined. 
TABLE  X 
Prevention of Viral Plaques after Removal of Leukocytes by Anti-HSV 
Antibody and Complement* 
Treatment of infected monolayers 
Leukocytes  Anti-HSV antibody  Complement 
No. of plaques  Virus  titer 
PFU, logl o 
-k  1:16  --  13  3.8 
+  1:16  -[-  1  1.1 
-k  1 : 16  Inact.  10  2.6 
+  1:4  --  1  1.6 
+  1:4  +  0  0 
+  1:4  Inact.  0  0 
+  Control~  --  7  2.7 
1 : 16  --  Confluent  NT§ 
1 : 16  +  Confluent  NT 
1 : 16  Inact.  Confluent  NT 
1 : 4  --  Confluent  NT 
1 : 4  +  Confluent  NT 
1 : 4  Inact.  Confluent  NT 
Control:~  --  Confluent  NT 
* Monolayers  infected  with  approximately  10  PFU  of HSV  were  overlaid  with  0.5  ml 
anti-HSV antibody and 0.5 ml of either complement, heat-inactivated complement, or GM. 
Leukocytes at a  ratio of 50:1 in 1.0 ml of GM or 1.0 ml of GM alone were added. 24 h  later, 
0.5  ml of either fresh complement, heat-inactivated  complement, or GM was added  to  the 
appropriate  monolayers. At  the end  of 72  h,  the leukocytes were  removed  and  the  mono- 
layers were washed and incubated with 0.25 ml of anti-HSV antibody and 0.25 ml of either 
complement  or  heat-inactivated  complement.  GM  then  was  added.  24  h  later  the  same 
procedure was repeated. At 144 h, plaques were counted and the virus titer was determined. 
]~ Antibody overlay medium. 
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plus  complement prevented the spread of the infection or  the destruction of 
the monolayers. 
DISCUSSION 
In vivo, certain viral infections persist or recur in the presence of high levels 
of neutralizing antibody. Presumably this happens because the virus spreads 
directly from one cell to another without being exposed to antiviral antibody. 
Although  there  have  been  few  studies  on  how  the  immunological  response 
of  the  host  actually  stops  the  cell-to-cell spread  of viruses,  it  has  generally 
been  assumed  that  the interaction of antiviral  antibody plus  complement or 
immune  lvanphocytes with  virus-induced  cell  surface  antigens  destroyed the 
infected cells and thereby stopped the spread of the infection (7,  10-12). 
To see whether antiviral antibody and complement actually could stop the 
infection from spreading, we used an in vitro system that resembled in many 
respects the in vivo state. Cells were infected with HSV, and then an antibody 
overlay was added. Under these conditions the virus spreads directly from one 
cell  to  another,  presumably through intercellular bridges  (1-3).  Extracellular 
virus was readily neutralized by the antibody overlay, thus preventing distant 
cells  from becoming infected. When  complement was  added  to  this  system, 
virus-infected cells  were  destroyed  (7);  but  as  shown  in  the present  study, 
the spread of the infection was not prevented. The failure to stop the spread 
of the infection suggested that the virus might be spreading from infected to 
uninfected cells before the infected cells  were lysed by antiviral antibody and 
complement.  Our  experiments  (Fig.  1)  show  this  to  be  the  case.  The  data, 
however, should be viewed with some caution since they are based on a popu- 
lation of cells rather than a  specific group of contiguous cells; moreover, it is 
difficult to  compare the precise sensitivity of the different assay procedures. 
Nonetheless,  the data from Fig.  1,  together with the fact that  the virus can 
spread from cell to cell in the presence of antiviral antibody and complement, 
support  the  contention that  the virus  enters uninfected cells  before the  cell 
in which it is synthesized is immunologically destroyed. Thus the viral spread 
is  always  one  step  ahead  of  the  destructive  capacity  of  antiviral  antibody 
and complement, and the infection persists. 
Although  there is still very little information as  to how cellular immunity 
operates in viral infections, several mechanisms have been proposed. First, the 
interaction  of  immune  lymphocytes with  viral-induced  cell  surface  antigens 
can result in cell destruction (11,  13,  14). Secondly, activation of lymphocytes 
or macrophages can lead to the release of biological mediators, such as inter- 
feron or lymphotoxin, that can inhibit viral replication and destroy cells  (13, 
15-20). Thirdly, macrophages might inhibit the infection by phagocytizing and 
digesting infectious particles (19, 21-23). The demonstration that HSV spreads 
from infected to  uninfected cells  at  approximately the  same  time  or  before 
substantial  amounts  of viral  antigens  appear  on  the  surface  of  the  infected 
cell  suggests  that  lymphocytes specifically immune  to  the  virus  would  have LODMELL  ET AL.  717 
no more opportunity to destroy the infected cell,  before transfer of virus  to 
adjacent cells,  than antiviral antibody and complement. Moreover, it appears 
to take immune lymphocytes considerably longer to destroy target cells than 
antiviral antibody and  complement  (7,  11,  24).  Evidence  that interferon or 
other  mediators released  from leukocytes are  not  responsible  for  inhibiting 
plaque development comes from two types of experiments. First, if leukoc)/tes 
were placed on monolayers 6,  12, or 24 h before infection with HSV and then 
removed,  the formation of plaques was not inhibited. Secondly, supernatant 
fluids from leukocyte cultures did not prevent  the  development of plaques. 
Moreover,  it  is  known  that  HSV  is  relatively resistant  to  interferon  (25). 
Phagocytosis of extracellular virus also seems to be of little consequence in our 
system since the virus is spreading through intercellular bridges. 
The specific cell type(s) in the peritoneal exudate responsible for inhibiting 
the  development of plaques is under study.  Since at least  75 %  of  the  cells 
in the exudate appear to be macrophages and since recent experiments in our 
laboratory  with  macrophages  purified  by  adherence  to  glass  showed  that 
these cells  can effectively suppress  the development of plaques, macrophages 
are the prime candidate. The ability of activated macrophages to damage or 
destroy normal and malignant cells has been well established, and is thought to 
be  an  important  component  in  delayed hypersensitivity reactions  (26-29). 
Our experiments suggest that leukocytes, presumably macrophages, also may 
play an important role in stopping the  cell-to-cell  spread of viral infections. 
At very high concentrations (50:1 or greater), leukocytes can destroy both in- 
fected and uninfected cells around infectious foci, thereby eliminating potential 
target cells for viral replication. At lower concentrations, the cells may not be 
destroyed, but the leukocytes may be toxic to them. This could lead to breaking 
of intercellular bridges and/or depression of the cell's metabolic processes.  If 
intercellular bridges are broken,  the virus cannot be  transferred to adjacent 
cells  without being exposed to antiviral antibody. If metabolic processes are 
shut  down,  this might inhibit  replication of  the  virus  within infected cells. 
In one case the infection is stopped because the virus cannot reach adjacent 
cells,  while in  the other  case it is halted because  the virus  cannot replicate. 
Evidence that the virus cannot reach adjacent cells without being exposed to 
antiviral  antibody comes from microscopic observations that showed loss  of 
continuity between adjacent cells, and from the data in Table X, which showed 
that  leukocyte-treated  cultures  could  be  cured  by  antiviral  antibody  and 
complement.  Evidence  that  high  concentrations  of  leukocytes  (50:1)  can 
inhibit replication of the virus  comes from the  experiment in which a  suffi- 
ciently high MOI  was used  to infect all  of the  cells  in  the  culture,  thereby 
eliminating the role of viral spread. 
The demonstration that the removal of leukocytes at the end of 72 h resulted 
in the appearance of plaques showed that leukocytes had suppressed  the in- 
fection, but had not destroyed all of the infected cells. Moreover, the appear- 
ance of plaques  at  144  h  suggested that intercellular bridges had been rees- 718  CELL-TO-CELL  SPREAD  OF  HSV:  PREVENTION  BY  LEUKOCYTES 
tablished.  We  reasoned that  if virus-infected cells  were exposed to  antiviral 
antibody and  complement during the period when  intercellular bridges  were 
broken, it might be possible to stop  the infection by destroying the infected 
cells before the virus was able to reach adjacent cells through the reestablished 
bridges.  Our  experiments showed that when low concentrations of anti-HSV 
(1:16)  were used,  the  addition of complement eliminated the  infection. The 
fact that high concentrations of anti-HSV (1:4) were able to eliminate the in- 
fection in  the absence of complement was unexpected, but there are at least 
two  possible  explanations.  First,  the  attachment  of  high  concentrations  of 
anti-HSV antibody to viral antigens on the surface of infected cells might have 
prevented or  blocked  the  reestablishment  of  intercellular bridges.  Secondly, 
infected cells that had been exposed to leukocytes, in contrast to infected cells 
that had not been exposed to leukocytes, might have been more susceptible to 
destruction and penetration by antiviral antibody. 
On  the basis of these and other observations we propose the following hy- 
pothesis to explain how the immune response stops viral infections that spread 
by a  cell-to-cell route. The  immunological  response  to  HSV  consists  of  two 
phases,  one  specific and  the  other nonspecific. Factors  that  are  chemotactic 
for polymorphonuclear and mononuclear leukocytes are specifically generated 
at  the  site  of  the  infection.  These  factors include  C5a,  a  cleavage product 
generated from the fifth component of complement by the interaction of anti- 
HSV  antibody with HSV  antigens  (30),  and soluble mediators released from 
immune lymphocytes after stimulation with HSV antigens (20).~ These medi- 
ators  attract  leukocytes to  the  site  of  the  infection,  where  they  exert  their 
toxic effect nonspecifically. This results in destruction of some of the infected 
cells and some of the surrounding uninfected cells to which the virus would have 
spread. In addition,  the leukocytes can inhibit viral replication and/or break 
intercellular  bridges  and  thereby prevent  the  virus  from  spreading  directly 
to  adjacent  cells  without being exposed to  antiviral  antibody.  Infected cells 
that survive the leukocyte attack can be destroyed by antiviral antibody and 
complement before intercellular bridges are reestablished. Thus both humoral 
and cellular components acting jointly are needed to cure the infection. 
Our  hypothesis  suggests  that  deficiencies in  the  host's  immune  response 
against  viral  infections must  be  sought  not  only in  the  amount  or type  of 
antibody produced but in the ability to generate chemotactic factors, attract 
and activate leukocytes, and destroy target cells. Better ways of getting leuko- 
cytes to the site of the infection might prove useful in treating viral infections 
that spread by a cell-to-cell route. 
SUMMARY 
Antibody to herpes simplex virus (HSV) plus complement destroyed HSV- 
infected cells  but did not stop the spread of the infection. Studies on the re- 
2 Rosenberg, G., R. Snyderman, and A. Notkins. UnpubUshed observations. LODMELL  ET  AL.  719 
lationship between the time of appearance of viral antigens on the cell surface, 
immunological  destruction  of  the  cells  by  antiviral  antibody  and  comple- 
ment, and transfer of the virus to adjacent cells showed that the virus spread 
from infected  to uninfected  cells before the  infected cells 'were susceptible  to 
immunological destruction. Incubation of infected monolayers with leukocytes, 
however, stopped the spread of the virus by nonspecifically damaging both in- 
fected and uninfected  cells and by presumably breaking intercellular  bridges. 
When  leukocytes were  removed from infected monolayers, viral plaques  de- 
veloped. If, however, antiviral antibody and complement were added to mono- 
layers before the  leukocytes were removed,  the  development of plaques  was 
prevented.  These  findings  suggest  that  both  antibody  and  leukocytes  are 
needed to cure HSV infections. 
The authors gratefully acknowledge the invaluable assistance of C. Wohlenberg, F. Shaw, 
G. Lewis, and M. Lombardi. 
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